Mechanism and in vivo activity of a small activating RNA targeting CEBPA, a novel therapeutic in clinical trials for liver disease

File(s)

Habib N et al Mechanism and In Vivo activity of a saRNA targeting CEBPA_ASGCT 2017 Abstractv2.pdf (79.55 KB)

Accepted version

Show more

Author(s)

Voutila, J

Reebye, V

Roberts, T

Blakey, D

Habib, R

more

Type

Conference Paper

Date Issued

2017-05-10

Date Acceptance

2017-05-10

Citation

Molecular Therapy, 2017, 25 (5), pp.34-34

URI

http://hdl.handle.net/10044/1/48854

DOI

https://www.dx.doi.org/10.1016/j.ymthe.2017.04.025

ISSN

1525-0024

Publisher

Elsevier (Cell Press)

Start Page

34

End Page

34

Journal / Book Title

Molecular Therapy

Volume

25

Issue

5

Copyright Statement

© 2017 Elsevier Inc. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/

Sponsor

Mina Therapeutics Ltd

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000401083600070&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Grant Number

P58698

Source

20th Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)

Subjects

Science & Technology

Life Sciences & Biomedicine

Biotechnology & Applied Microbiology

Genetics & Heredity

Medicine, Research & Experimental

Research & Experimental Medicine

Publication Status

Published

Start Date

2017-05-10

Finish Date

2017-05-13

Coverage Spatial

Washington, DC